Abstract
Background and Purpose
Cerebrovascular complications are a rare manifestation of pheochromocytoma. We report a case of pheochromocytoma presenting initially with reversible posterior leukoencephalopathy and subsequently a cerebral infarction.
Summary of Case
A patient with a prior history of episodic hypertension and reversible posterior leukoencephalopathy presented with headache, palpitations, and weakness of the right leg. A magnetic resonance angiogram revealed narrowing of the basilar and right middle cerebral artery. She was diagnosed as having presumed vasculitis and underwent a conventional cerebral angiogram during which she developed a hypertensive crisis and worsening neurological deficit. Further investigations revealed the presence of a pheochromocytoma, which was subsequently resected.
Conclusions
It is important to be cognizant of the possibility of pheochromocytoma in patients presenting with hypertension and cerebrovascular manifestations, as commonly used investigations (e.g. catheter angiography) and treatment modalities (e.g. β-blockers to treat hypertension, corticosteroids to treat suspected vasculitis, etc.) can lead to life threatening complications.
Similar content being viewed by others
References
Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101.
Razavi M, Bendixen B, Maley JE, Zargarian M, Razavi B, Adams HP. CNS pseudovasculitis in a patient with pheochromocytoma. Neurology. 1999;52:1088–90.
Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. CPEP study group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992–1005.
Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006;354:980–2.
Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drugs. 2007;30:1031–62.
Raisanen J, Shapiro B, Glazer GM, Desai S, Sisson JC. Plasma catecholamines in pheochromocytoma: effect of urographic contrast media. Am J Roentgenol. 1984;143:43–6.
Acknowledgments
Conflicts of interest:
Tamara Majic: None. Venkatesh Aiyagari: Consultancy for Boehringer-Ingelheim.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Majic, T., Aiyagari, V. Cerebrovascular Manifestations of Pheochromocytoma and the Implications of a Missed Diagnosis. Neurocrit Care 9, 378–381 (2008). https://doi.org/10.1007/s12028-008-9105-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-008-9105-8